.

Efficacy and Safety of Enoxaparin 20 Mg Subcutaneously in Patients With Chronic Kidney Disease Stages 4 and 5 for Deep Vein Thrombosis Prophylaxis

LAUR Repository

Show simple item record

dc.creator Karaoui, Lamis en_US
dc.creator Tawil, Samah en_US
dc.date.accessioned 2016-09-30T07:29:18Z
dc.date.available 2016-09-30T07:29:18Z
dc.date.datecopyrighted 2011 en_US
dc.identifier.issn 0090-3493 en_US
dc.identifier.uri http://hdl.handle.net/10725/4464
dc.language.iso en en_US
dc.title Efficacy and Safety of Enoxaparin 20 Mg Subcutaneously in Patients With Chronic Kidney Disease Stages 4 and 5 for Deep Vein Thrombosis Prophylaxis en_US
dc.type Article en_US
dc.description.version Published en_US
dc.creator.school SOP en_US
dc.creator.identifier 200101817 en_US
dc.creator.department Pharmacy Practice Department en_US
dc.description.embargo N/A en_US
dc.relation.ispartof Critical Care Medicine en_US
dc.description.volume 39 en_US
dc.description.issue 12 en_US
dc.article.pages 225 en_US
dc.identifier.doi http://dx.doi.org/10.1097/01.ccm.0000408627.24229.88 en_US
dc.identifier.ctation Karaoui, L., & Tawil, S. (2011). EFFICACY AND SAFETY OF ENOXAPARIN 20 MG SUBCUTANEOUSLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4 AND 5 FOR DEEP VEIN THROMBOSIS PROPHYLAXIS. Critical Care Medicine, 39(12), 225. en_US
dc.creator.email lamis.karaoui@lau.edu.lb en_US
dc.description.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url http://journals.lww.com/ccmjournal/Citation/2011/12001/801__EFFICACY_AND_SAFETY_OF_ENOXAPARIN_20_MG.757.aspx en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR


Advanced Search

Browse

My Account